• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 24, 2023 at 10:42: AM
via As the infectious diseases market expands, Pfizer, Gilead and GSK will climb to the top of the industry and emerge as the most dominant players in the space, according to data analytics and consultancy GlobalData.

article source
 

<



Similar threads

cafead
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA&#039;s UC...
Replies
0
Views
200
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Replies
0
Views
398
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer, Moderna and Gilead reputations climb on COVID-19 vaccine and treatment news,...
Replies
0
Views
195
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Replies
0
Views
168
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
Replies
0
Views
169
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote